awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37733456-1F1C23C3-7BB3-4062-B51F-065F8E1050E7
Q37733456-1F1C23C3-7BB3-4062-B51F-065F8E1050E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37733456-1F1C23C3-7BB3-4062-B51F-065F8E1050E7
Additional Risk Minimisation Measures for Medicinal Products in the European Union: A Review of the Implementation and Effectiveness of Measures in the United Kingdom by One Marketing Authorisation Holder.
P2860
Q37733456-1F1C23C3-7BB3-4062-B51F-065F8E1050E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37733456-1F1C23C3-7BB3-4062-B51F-065F8E1050E7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1dae6dd0aa234112af8f366e156598f259379a99
P2860
The risk of infections in hematologic patients treated with rituximab is not influenced by cumulative rituximab dosage - a single center experience.